1. Home
  2. RNAZ vs INTZ Comparison

RNAZ vs INTZ Comparison

Compare RNAZ & INTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • INTZ
  • Stock Information
  • Founded
  • RNAZ 2016
  • INTZ 1983
  • Country
  • RNAZ United States
  • INTZ United States
  • Employees
  • RNAZ N/A
  • INTZ N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • INTZ Computer Communications Equipment
  • Sector
  • RNAZ Health Care
  • INTZ Telecommunications
  • Exchange
  • RNAZ Nasdaq
  • INTZ Nasdaq
  • Market Cap
  • RNAZ 6.1M
  • INTZ 42.0M
  • IPO Year
  • RNAZ 2021
  • INTZ 2020
  • Fundamental
  • Price
  • RNAZ $7.97
  • INTZ $2.29
  • Analyst Decision
  • RNAZ Strong Buy
  • INTZ Buy
  • Analyst Count
  • RNAZ 1
  • INTZ 2
  • Target Price
  • RNAZ $280.00
  • INTZ $6.25
  • AVG Volume (30 Days)
  • RNAZ 31.2K
  • INTZ 970.9K
  • Earning Date
  • RNAZ 08-13-2025
  • INTZ 08-12-2025
  • Dividend Yield
  • RNAZ N/A
  • INTZ N/A
  • EPS Growth
  • RNAZ N/A
  • INTZ N/A
  • EPS
  • RNAZ N/A
  • INTZ N/A
  • Revenue
  • RNAZ N/A
  • INTZ $6,415,000.00
  • Revenue This Year
  • RNAZ N/A
  • INTZ $35.18
  • Revenue Next Year
  • RNAZ N/A
  • INTZ $32.43
  • P/E Ratio
  • RNAZ N/A
  • INTZ N/A
  • Revenue Growth
  • RNAZ N/A
  • INTZ 18.07
  • 52 Week Low
  • RNAZ $6.15
  • INTZ $0.35
  • 52 Week High
  • RNAZ $924.00
  • INTZ $7.34
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 47.04
  • INTZ 58.59
  • Support Level
  • RNAZ $7.32
  • INTZ $2.03
  • Resistance Level
  • RNAZ $8.48
  • INTZ $2.50
  • Average True Range (ATR)
  • RNAZ 0.58
  • INTZ 0.21
  • MACD
  • RNAZ 0.41
  • INTZ -0.00
  • Stochastic Oscillator
  • RNAZ 70.77
  • INTZ 51.39

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.

Share on Social Networks: